文献速递神经肿瘤

自动ADC分析预测低级别胶质瘤基因型:与T2-FLAIR错配征的关联

Automated apparent diffusion coefficient analysis for genotype prediction in lower grade glioma: association with the T2-FLAIR mismatch sign.
PubMed 文献 · J Neurooncol · 2020-09-09

本研究基于134例内部队列和93例外部验证队列,开发全肿瘤ADC指标(VADC>1.5)自动识别IDH突变且1p/19q未共缺失的低级别胶质瘤。VADC>1.5在内部和验证队列的AUC分别为0.80和0.81,阈值0.35时特异性>90%,且与T2-FLAIR错配征高度一致,联合两者可提高敏感性。

要点

  • VADC>1.5是识别IDHmut-Noncodel低级别胶质瘤的稳健指标,两队列特异性均>90%。
  • VADC>1.5≥0.35与T2-FLAIR错配征高度一致,联合两者可提高检测敏感性。
  • 37例T2-FLAIR错配征阳性者均为IDHmut-Noncodel,其中86%同时VADC>1.5≥0.35。

核心结论

  • 高ADC肿瘤亚区是IDHmut-Noncodel低级别胶质瘤的稳健指标,VADC>1.5在内部和验证队列均达到>90%分类特异性。

研究设计与样本

  • 回顾性队列研究,内部队列N=134用于确定最佳阈值,外部验证队列N=93来自The Cancer Imaging Archive。
  • 使用全肿瘤ADC指标(包括VADC>1.5)进行分类,并与放射科医生识别的T2-FLAIR错配征比较及联合评估。

主要发现

  • 内部队列VADC>1.5分类IDHmut-Noncodel的AUC为0.80,阈值0.35时敏感性/特异性=0.57/0.93。
  • 验证队列VADC>1.5≥0.35的敏感性/特异性=0.57/0.91,AUC=0.81。
  • 两组合计37例T2-FLAIR错配征阳性者均为IDHmut-Noncodel,其中32/37(86%)同时VADC>1.5≥0.35。
  • 另有23例IDHmut-Noncodel病例VADC>1.5≥0.35但T2-FLAIR错配征阴性。

关键数值与推荐

  • VADC>1.5阈值0.35在内部队列敏感性/特异性=0.57/0.93,验证队列=0.57/0.91。
  • VADC>1.5在内部和验证队列的AUC分别为0.80和0.81。
  • T2-FLAIR错配征阳性37例均为IDHmut-Noncodel,其中86%同时VADC>1.5≥0.35。

临床怎么用

  • 可自动计算VADC>1.5辅助识别IDHmut-Noncodel低级别胶质瘤,减少对放射科医生主观判读T2-FLAIR错配征的依赖。
  • 联合VADC>1.5与T2-FLAIR错配征可提高检测IDHmut-Noncodel的敏感性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The prognosis of lower grade glioma (LGG) patients depends (in large part) on both isocitrate dehydrogenase (IDH) gene mutation and chromosome 1p/19q codeletion status. IDH-mutant LGG without 1p/19q codeletion (IDHmut-Noncodel) often exhibit a unique imaging appearance that includes high apparent diffusion coefficient (ADC) values not observed in other subtypes. The purpose of this study was to develop an ADC analysis-based approach that can automatically identify IDHmut-Noncodel LGG. METHODS: Whole-tumor ADC metrics, including fractional tumor volume with ADC > 1.5 × 10-3mm2/s (VADC>1.5), were used to identify IDHmut-Noncodel LGG in a cohort of N = 134 patients. Optimal threshold values determined in this dataset were then validated using an external dataset containing N = 93 cases collected from The Cancer Imaging Archive. Classifications were also compared with radiologist-identified T2-FLAIR mismatch sign and evaluated concurrently to identify added value from a combined approach. RESULTS: VADC>1.5 classified IDHmut-Noncodel LGG in the internal cohort with an area under the curve (AUC) of 0.80. An optimal threshold value of 0.35 led to sensitivity/specificity = 0.57/0.93. Classification performance was similar in the validation cohort, with VADC>1.5 ≥ 0.35 achieving sensitivity/specificity = 0.57/0.91 (AUC = 0.81). Across both groups, 37 cases exhibited positive T2-FLAIR mismatch sign-all of which were IDHmut-Noncodel. Of these, 32/37 (86%) also exhibited VADC>1.5 ≥ 0.35, as did 23 additional IDHmut-Noncodel cases which were negative for T2-FLAIR mismatch sign. CONCLUSION: Tumor subregions with high ADC were a robust indicator of IDHmut-Noncodel LGG, with VADC>1.5 achieving > 90% classification specificity in both internal and validation cohorts. VADC>1.5 exhibited strong concordance with the T2-FLAIR mismatch sign and the combination of both parameters improved sensitivity in detecting IDHmut-Noncodel LGG.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Aliotta E, Dutta SW, Feng X, et al. Automated apparent diffusion coefficient analysis for genotype prediction in lower grade glioma: association with the T2-FLAIR mismatch sign. J Neurooncol. 2020. PMID: 32909115. doi:10.1007/s11060-020-03611-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。